Analysis of Galectin-Binding Receptors on B Cells

Area of Science:

• Immunology
• Glycobiology
• Cancer Biology

Background:

• Galectins (β-galactoside-binding lectins) play critical roles in disease, including cancer progression, immune evasion, and autoimmunity.
• Their function is mediated through interactions with specific glycan counter-receptor ligands on cell surfaces.
• Current methods for analyzing galectins do not adequately detect these native glycan ligands.

Purpose of the Study:

• To present novel methods for detecting and identifying glycan counter-receptor ligands for galectin-3 (Gal-3) and galectin-9 (Gal-9).
• To establish a framework for analyzing galectin-ligand interactions in specific cell types, using human B cells as a model.
• To facilitate the understanding of galectin-mediated cellular signaling in disease.

Main Methods:

• Isolation of human B-cell subsets from fresh tonsil tissue.
• Assaying galectin-3 and galectin-9 binding activity on isolated human B cells.
• Identification of specific galectin-3 and galectin-9 ligands on the surface of human B cells.

Main Results:

• Successful development and application of methods to detect galectin-3 and galectin-9 binding on human B cells.
• Identification of specific glycan counter-receptor ligands for galectin-3 and galectin-9 on B-cell surfaces.
• Demonstration of a methodology applicable to any cell type for studying galectin-mediated phenotypes.

Conclusions:

• The developed methods enable the detection and identification of native galectin ligands on cell surfaces.
• Understanding these galectin-ligand interactions provides critical insights into cellular signaling pathways in disease.
• This research opens new avenues for identifying novel therapeutic targets in cancer and immunology.